Sotrovimab constitute a innovative class of immunoglobulin treatments designed to neutralize the SARS-CoV-2 pathogen . Initially , sotrovimab, engineered by GSK , demonstrated significant efficacy https://www.targetmol.com/compound/sotrovimab